Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose
of these consensus statements is to provide a review of the literature and specific, updated …

Helicobacter pylori (H. pylori) is an extremely common, yet underappreciated, pathogen that
is able to alter host physiology and subvert the host immune response, allowing it to persist …

A 29-year-old man presents with intermittent epigastric discomfort, without weight loss or
evidence of gastrointestinal bleeding. He reports no use of aspirin or nonsteroidal …

Peptic ulcer disease had a tremendous effect on morbidity and mortality until the last
decades of the 20th century, when epidemiological trends started to point to an impressive …

Data are available such that choice of Helicobacter pylori therapy for an individual patient
can be reliably predicted. Here, treatment success is defined as a cure rate of 90% or …

Abstract The Asia–Pacific Consensus Conference was convened to review and synthesize
the most current information on Helicobacter pylori management so as to update the …

Objective To do a systematic review and meta-analysis of studies comparing sequential
therapy for eradication of Helicobacter pylori with pre-existing and new therapies, thus …

Background: Over the past few years, the profile of Helicobacter pylori infection has changed
in Japan. In particular, the relationship between H. pylori and gastric cancer has been …

Background Whether sequential treatment can replace triple therapy as the standard
treatment for Helicobacter pylori infection is unknown. We compared the efficacy of …

Helicobacter pylori (H. pylori) is an important major cause of peptic ulcer disease and gastric
malignancies such as mucosa-associated lymphoid tissue lymphoma and gastric …